H

Hansa Biopharma AB (publ)

164 employees

Hansa Biopharma is a biopharmaceutical company that develops immunomodulatory treatments for people living with rare immunological diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Biopharmaceuticals
Health Care
Sepsis
Kidney transplantation
Immunomodulatory
Orphan drug
Antibody glycosylation
In vitro diagnostics
Drug discovery
Rare diseases
Clinical development
Autoimmune disease

Date founded

2007

Funding rounds raised

Total raised

$70M

from 1 investors over 1 rounds

H

Hansa Biopharma AB (publ) raised $70M on July 18, 2022

Investors: -

FAQ